John Lacey III insider trades
Open-market stock purchases and sales by John Lacey III, Director at Provectus Biopharmaceuticals, Inc, from SEC Form 4 filings since Sep 30, 2024.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 30, 2026 | PVCT Provectus Biopharmaceuticals, Inc | Bought (not open market) | — |
Companies traded
- PVCT Provectus Biopharmaceuticals, Inc: other filings, last Jun 30, 2026